T1	Participants 116 154	advanced head and neck cancer patients
T2	Participants 598 762	patients with unresectable grade I/II head and neck cancer who were not suitable for irradiation treatment (T any N3 or T4 N2C), metastatic or previously irradiated
T3	Participants 890 938	total of 170 patients were included in the study
T4	Participants 3186 3215	head and neck cancer patients
